Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Non Metastatic Breast Cancer × Tamoxifen × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 245 Carcinoma, Intraductal, Noninfiltrating 21 Breast Carcinoma In Situ 17 Breast Neoplasms, Male 11 Neoplasm Metastasis 10 Neoplasms 6 Inflammatory Breast Neoplasms 6 Breast Cancer Female 4 Obesity 3 Carcinoma, Ductal, Breast 3 Sleep Wake Disorders 2 Hot Flashes 2 Endometrial Neoplasms 2 ER+ Breast Cancer 2 Carcinoma, Lobular 2 Vitamin D Deficiency 1 Triple Negative Breast Neoplasms 1 Sarcoma 1 Risk Reduction Behavior 1 Recurrence 1 Pulmonary Fibrosis 1 Primary Breast Cancer 1 Premenopausal Breast Cancer 1 Precancerous Conditions 1 Patient Acceptance of Health Care 1 Paget's Disease, Mammary 1 Nutrition Disorders 1 Non Metastatic Breast Cancer 1 Newly Diagnosed Hormone Positive Clinical Stage 1 or 2 Breast Cancer 1 Neoplasm Recurrence, Local 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01220076 2021-03-12

TAM

Institut Cancerologie de l'Ouest

Phase 2 Completed

Non Metastatic Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡